ZURA BIO LTD (ZURA) Stock Income Statement
USA - NASDAQ:ZURA - KYG9TY5A1016 - Common Stock
2.99 USD
+0.58 (+24.07%)
3.2 USD
+0.21 (+7.02%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 0.00 | 0.00 | 203.00K | N/A | N/A | |||
| Operating Expenses | 66.31M | 55.19M | 62.64M | 2.68M | 890.00K | |||
| Research and Development | 31.28M | 24.40M | 44.00M | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 34.78M | 30.79M | 18.64M | 2.68M | 890.00K | |||
| Operating Income | -66.31M | -55.19M | -62.64M | -2.68M | -890.00K | |||
| Interest Income/Expense | 3.97M | 2.76M | 4.30M | 6.22M | 10.26M | |||
| Other Income/Expense | -2.00K | 28.00K | -2.23M | 0.00 | -2.52M | |||
| Income Before Taxes | -61.77M | -52.40M | -60.56M | 3.55M | 6.85M | |||
| Income Tax | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Net Income | -62.43M | -45.39M | -69.24M | 3.55M | 6.85M | |||
| EBITDA | N/A | -55.18M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.72 | -0.60 | -2.09 | 0.21 | 0.40 | |||
| Non GAAP EPS | -0.72 | -0.55 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD